U.S., Aug. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07113522) titled 'A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease' on July 15.
Brief Summary: This is a Phase 2, multicenter, platform study in adult participants with IBD (moderately to severely active Crohn's Disease or Ulcerative Colitis). The primary goal of this study is to assess the safety and efficacy of multiple investigational drugs.
Study Start Date: June 26
Study Type: INTERVENTIONAL
Condition:
Inflammatory Bowel Disease (IBD)
Ulcerative Colitis (UC)
Crohn's Disease
Intervention:
DRUG: MT-501
MT-501 Tablets
Recruitment Status: RECRUITING
Sponsor: Mirador Therapeutics, Inc.
Published by HT Digital Content Serv...